Healthcare Services Spain

Spain Pharmacovigilance Services Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Spain Pharmacovigilance Services Market Industry Trends and Forecast to 2034: Segmented by (Service, Model, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Spain · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $161.5 Mn Placeholder estimate
Estimate 2025 $177.3 Mn 1.7% of the global market
Projected 2034 $411.4 Mn 132% Adds $234.0 Mn over 9 forecast years
CAGR 2025–2034 9.8% Faster than 67% of 107 Healthcare Services markets here
Key players 5
  • Spain is 1.69% of the global market.
  • In Europe, the largest is Germany at $380.0 Mn.
  • Fastest growing: Russia at 10.9% a year.
  • Spain ranks 5th of 6 by size in Europe.

Market size projection

Spain

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$234.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Pharmacovigilance Services Market market size by year, Spain
YearMarket sizeChange that yearSince 2025
2024 (estimate) $161.5 Mn — —
2025 (base) $177.3 Mn +$15.8 Mn —
2026 (forecast) $194.7 Mn +$17.4 Mn +9.8%
2027 (forecast) $213.8 Mn +$19.1 Mn +20.6%
2028 (forecast) $234.8 Mn +$21.0 Mn +32.4%
2029 (forecast) $257.8 Mn +$23.0 Mn +45.3%
2030 (forecast) $283.0 Mn +$25.3 Mn +59.6%
2031 (forecast) $310.8 Mn +$27.7 Mn +75.2%
2032 (forecast) $341.2 Mn +$30.5 Mn +92.4%
2033 (forecast) $374.7 Mn +$33.4 Mn +111.3%
2034 (forecast) $411.4 Mn +$36.7 Mn +132%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Spain Pharmacovigilance Services Market Analysis at a glance
Market size, 2025$177.3 Mn placeholder estimate
Forecast, 2034$411.4 Mn placeholder estimate
Growth (CAGR), 2025–20349.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsService, model and end user (see all)
Key playersIQVIA, ArisGlobal, Parexel, Accenture, Cognizant (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Spain Pharmacovigilance Services Market Analysis Executive Summary

Pharmacovigilance services collect and review reports of side effects to keep medicines safe after approval.

Key segments of the pharmacovigilance Services market include service (Case Processing, Signal Detection and Risk Management) and model (Outsourced and In-House Software).

Bar chart: Spain Pharmacovigilance Services market size, 2024–2034, placeholder estimates. $161.5 Mn in 2024, $177.3 Mn in 2025 and $411.4 Mn in 2034, 9.8% CAGR.
Spain Pharmacovigilance Services market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Spain Pharmacovigilance Services Market Dynamics

Market Growth Drivers

Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the pharmacovigilance Services market. Many companies now outsource work they used to do in-house.

Opportunity

Advanced therapies, AI-driven operations and expansion in India, China and Southeast Asia give the pharmacovigilance Services market room to grow.

Market Restraints

Capacity shortages, strict quality rules, data security concerns and pricing pressure hold back the pharmacovigilance Services market.

Competitive Landscape for Pharmacovigilance Services Market in Spain

The pharmacovigilance Services market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Pharmacovigilance Services Market in Spain

Pharmacovigilance Services in Spain: payment

The National Health System (SNS), run by the regions, gives universal public care.⁠[1]

[1] Spanish Ministry of Health. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Licensing, quality standards and payment models from public and private payers shape how pharmacovigilance Services services are delivered and paid for in Spain. Government health programs and insurance coverage are key to access.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Pharmacovigilance Services right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Pharmacovigilance Services in context

Spain compared

  • Health spending per person: 3,107 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 6 countries we cover in Europe.[1]
  • Doctors: 4.29 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 6 countries we cover in Europe.[2]
  • People aged 65 and over: 21.6% of people (2025). World: 10.4% of people (2025). 4th highest of the 6 countries we cover in Europe.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 18 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 18 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Pharmacovigilance Services market in Spain?
Placeholder estimate: about $177.3 Mn in 2025, rising to about $411.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Pharmacovigilance Services market in Spain growing?
Placeholder estimate: about 9.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Pharmacovigilance Services market report cover?
The report splits the market by service (Case Processing, Signal Detection, Risk Management, Literature Monitoring), model (Outsourced, In-House Software) and end user (Hospitals, Clinics, Home Care, Corporate and Payer Clients).
Who are the key players in the Pharmacovigilance Services market?
Key players include IQVIA, ArisGlobal, Parexel, Accenture and Cognizant.
What is driving the Pharmacovigilance Services market?
Growing drug pipelines, more complex biologics, cost pressure on drug makers and the need for speed are driving the pharmacovigilance Services market. Many companies now outsource work they used to do in-house.
How is healthcare paid for in Spain?
The National Health System (SNS), run by the regions, gives universal public care. Source: Spanish Ministry of Health. Checked 14 Nov 2026.
How much research is published on Pharmacovigilance Services?
PubMed lists 7,687 papers on Pharmacovigilance Services added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Healthcare Services reports in Spain

See all

Related on drug development and manufacturing and clinical trials

See the topic